Wehling | Drug Therapy for the Elderly | Buch | 978-3-7091-0911-3 | sack.de

Buch, Englisch, 356 Seiten, Format (B × H): 178 mm x 254 mm, Gewicht: 783 g

Wehling

Drug Therapy for the Elderly


2013
ISBN: 978-3-7091-0911-3
Verlag: Springer Vienna

Buch, Englisch, 356 Seiten, Format (B × H): 178 mm x 254 mm, Gewicht: 783 g

ISBN: 978-3-7091-0911-3
Verlag: Springer Vienna


With people aged 65 years and older currently making up the fastest growing age group throughout the world, the demographic revolution of an aging society will inevitably lead to increased pressure to develop a rationalistic and age-tailored process of diagnosis and treatment among the elderly. As aging people often suffer from several chronic diseases and are being treated with multiple medications concurrently, unwanted drug interactions occur more frequently.
Whereas recent approaches have recommended to remove particular drugs from the medication regimen to avoid adverse effects, Drug Therapy for the Elderly underlines both indispensable and dispensable elements of drug treatment in order to provide an overall assessment of drugs suitable for the aged. In view of the multimorbidity and polypharmacy situations experienced by elderly patients, this book takes into account the special needs and requirements shown by this group, thus serving as a timely reference for physicians who treat the elderly.

Wehling Drug Therapy for the Elderly jetzt bestellen!

Zielgruppe


Professional/practitioner


Autoren/Hrsg.


Weitere Infos & Material


Foreword.-

Part 1: General aspects.-

Part 2: Special considerations with regard to organ systems based on geriatric clinical importance.-

Part 3: Pharmacotherapy and geriatric syndromes.-

Part 4: Further problem areas in gerontopharmacotherapy and pragmatic recommendations.


With people aged 65 years and older currently making up the fastest growing age group throughout the world, the demographic revolution of an aging society will inevitably lead to increased pressure to develop a rationalistic and age-tailored process of diagnosis and treatment among the elderly. As aging people often suffer from several chronic diseases and are being treated with multiple medications concurrently, unwanted drug interactions occur more frequently.
Whereas recent approaches have recommended to remove particular drugs from the medication regimen to avoid adverse effects, Drug Therapy for the Elderly underlines both indispensable and dispensable elements of drug treatment, providing the practitioner with:

- Background information on the elderly population regarding their needs for particular drugs (with an eye to frailty, co-morbidity patterns, and special sensitivities regarding drug metabolism and excretion)
- Practical advice about drug treatment surveillance parameters in the elderly
- In-depth discussion of drugs in relation to the elderly with specific diagnoses
- Integration of multimorbidity/polypharmacy situations into prioritization schemes
- A plan for how to deal with the complexity of polypharmacy situations in a five-minute consultation

An original classification of drugs is proposed by the editor which relates the power of effects, prognostic data, and tolerability to a prioritization scoring system. This approach is the first to not only provide a negative listing, but also integrates positive data into an overall assessment for drugs fit for the aged. Therefore, Drug Therapy for the Elderly serves as a timely reference for a wide array of physicians.



Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.